Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivors ; volume:9 ; number:1 ; day:7 ; month:7 ; year:2023 ; pages:1-10 ; date:12.2023
Cardio-Oncology ; 9, Heft 1 (7.7.2023), 1-10, 12.2023
- Creator
-
Wong-Siegel, Jeannette R.
Hayashi, Robert J.
Foraker, Randi
Mitchell, Joshua D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40959-023-00181-2
- URN
-
urn:nbn:de:101:1-2023101110203695896076
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wong-Siegel, Jeannette R.
- Hayashi, Robert J.
- Foraker, Randi
- Mitchell, Joshua D.
- SpringerLink (Online service)
Other Objects (12)
Synergistic Toxicities from Multiple Therapies for Synchronous Malignancies
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
Anthracycline Chemotherapy and Cardiotoxicity
Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Synergistic Toxicities from Multiple Therapies for Synchronous Malignancies
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
Anthracycline Chemotherapy and Cardiotoxicity
Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy
Correction: Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Synergistic Toxicities from Multiple Therapies for Synchronous Malignancies
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
Impact of late toxicities on quality of life for survivors of nasopharyngeal carcinoma
Anthracycline-induced hypertension in pediatric cancer survivors: unveiling the long-term cardiovascular risks
Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy
Resting and exercise arterial dysfunction in anthracycline-treated adult survivors of childhood cancers
Choroidal remodeling following different anti-VEGF therapies in neovascular AMD
Approaches for monitoring and treating cardiomyopathy among cancer survivors following anthracycline or thoracic radiation treatment
Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
Anthracycline Chemotherapy and Cardiotoxicity
Left Ventricle Size Correlates with Peak Exercise Capacity in Pediatric Cancer Survivors Exposed to Anthracycline Chemotherapy